Royal Bank of Canada’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3K Sell
505
-136
-21% -$808 ﹤0.01% 6376
2025
Q1
$2K Buy
641
+297
+86% +$927 ﹤0.01% 6214
2024
Q4
$2K Sell
344
-2,235
-87% -$13K ﹤0.01% 6239
2024
Q3
$37K Buy
2,579
+2,300
+824% +$33K ﹤0.01% 5380
2024
Q2
$20K Buy
279
+31
+13% +$2.22K ﹤0.01% 5691
2024
Q1
$15K Sell
248
-628
-72% -$38K ﹤0.01% 5598
2023
Q4
$64K Sell
876
-78
-8% -$5.7K ﹤0.01% 5346
2023
Q3
$37K Sell
954
-17
-2% -$659 ﹤0.01% 5447
2023
Q2
$55K Buy
971
+547
+129% +$31K ﹤0.01% 5285
2023
Q1
$27K Buy
424
+139
+49% +$8.85K ﹤0.01% 5532
2022
Q4
$8K Buy
285
+1
+0.4% +$28 ﹤0.01% 6150
2022
Q3
$8K Sell
284
-30,000
-99% -$845K ﹤0.01% 6064
2022
Q2
$581K Buy
30,284
+29,964
+9,364% +$575K ﹤0.01% 3533
2022
Q1
$26K Sell
320
-219
-41% -$17.8K ﹤0.01% 5986
2021
Q4
$49K Buy
539
+267
+98% +$24.3K ﹤0.01% 5857
2021
Q3
$35K Buy
272
+75
+38% +$9.65K ﹤0.01% 5850
2021
Q2
$22K Sell
197
-11
-5% -$1.23K ﹤0.01% 6025
2021
Q1
$31K Buy
208
+68
+49% +$10.1K ﹤0.01% 5688
2020
Q4
$16K Buy
140
+32
+30% +$3.66K ﹤0.01% 5618
2020
Q3
$8K Sell
108
-2
-2% -$148 ﹤0.01% 5522
2020
Q2
$12K Sell
110
-37
-25% -$4.04K ﹤0.01% 5303
2020
Q1
$16K Sell
147
-69
-32% -$7.51K ﹤0.01% 5144
2019
Q4
$34K Buy
216
+109
+102% +$17.2K ﹤0.01% 5037
2019
Q3
$16K Hold
107
﹤0.01% 4994
2019
Q2
$12K Sell
107
-5
-4% -$561 ﹤0.01% 5136
2019
Q1
$12K Buy
112
+4
+4% +$429 ﹤0.01% 5063
2018
Q4
$9K Sell
108
-21
-16% -$1.75K ﹤0.01% 5153
2018
Q3
$21K Buy
129
+2
+2% +$326 ﹤0.01% 5053
2018
Q2
$25K Buy
+127
New +$25K ﹤0.01% 4865